Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Ascentage Pharma Group Inc.)"
Count: 38
Selected: 0
NCT IDTitle
NCT04126707The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans
NCT04126681A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase
NCT03882281Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia
NCT03594422A Study of HQP1351 in Patients With GIST or Other Solid Tumors
NCT03585322APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B
NCT05186012APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma
NCT05147467Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
NCT04964518A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
NCT04946864A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer
NCT04942067APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma
NCT04893759A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors
NCT04785196APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors
NCT04674514APG-2575 Monotherapy or in Combination With Lenalidomide/DXMS in Subjects With Relapsed or Refractory Multiple Myeloma
NCT04643405APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma
NCT04568265A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B
NCT04501120Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory AML
NCT04496349A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With T-PLL
NCT04494503Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
NCT04358393A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
NCT04354727A Study of APG-1252 in Patients With Myelofibrosis Who Progressed After Initial Therapy
NCT04284488Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors
NCT04275518A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
NCT04260217APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia
NCT04260022Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
NCT04215809Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
NCT04210037Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
NCT04001777A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients
NCT03917043APG-2449 in Patients With Advanced Solid Tumors
NCT03913949A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
NCT03883100A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation
NCT03883087A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation
NCT03611868A Study of APG-115 in Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
NCT03537482APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
NCT03387332APG-1252 in Patients With SCLC or Advanced Solid Tumors
NCT03386526APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies
NCT03080311A Study of APG-1252 in Patients With SCLC or Other Solid Tumors
NCT02935907APG-115 in Patients With Advanced Solid Tumors or Lymphomas
NCT03781986APG-115 in Salivary Gland Cancer Trial